This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue
by Indrajit Bandyopadhyay
Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.
ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change
medical medical-devices
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise
by Indrajit Bandyopadhyay
ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.
ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change
medical medical-devices
Revvity to Launch Signals for Startups for Emerging Biotech Companies
by Zacks Equity Research
RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.
RVTYNegative Net Change ISRGPositive Net Change CAHPositive Net Change WSTPositive Net Change
medical medical-devices
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure
by Indrajit Bandyopadhyay
ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.
ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change
medical medical-devices
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth?
by Zacks Equity Research
Intuitive Surgical's valuation has eased as U.S. procedure growth slows, but margin gains, AI software expansion and global growth could support its premium.
ISRGPositive Net Change IDXXPositive Net Change GKOSNegative Net Change
medical medical-devices
Home BancShares (HOMB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOMBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AVAHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Labcorp Prepares to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.
LHNegative Net Change HSICPositive Net Change ALCNegative Net Change CVSNegative Net Change
earnings medical medical-devices
The Best "Strong Buy" Stocks to Buy as Q2 Earnings Season Heats Up
by Benjamin Rains
Finding the best Zacks Rank #1 (Strong Buy) stocks out of a group of over 200 highly-ranked stocks to consider buying as Q2 earnings season ramps up.
BWAYNegative Net Change
medical medical-devices
GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration
by Zacks Equity Research
GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.
GEHCNegative Net Change ISRGPositive Net Change CAHPositive Net Change WSTPositive Net Change
medical medical-devices